BSE filing, NSE: AAYUSH. Summary written from the filing by ALFA Finder's alert engine.
Aayush Wellness Ltd: key numbers
- Share price
- ₹24.07
- Market cap
- ₹117.2 Cr
- Revenue (annual)
- ₹155.5 Cr
- Net profit (annual)
- ₹3.98 Cr
- P/E (TTM)
- 27.6×Sector 38.3×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aayush Wellness Ltd
All →Aayush Wellness Board Meeting Date
Aayush Wellness intimated that its Board will meet on 3 November 2026 to consider Q2 and H1 FY27 unaudited results. No financial figures or monetary values are disclosed in this advance notice.
Aayush Wellness Product Launch
Aayush Wellness Limited has launched 'Aayush Calcium Vitamin Tablets' to expand its nutraceutical portfolio. The new product targets the growing bone and joint health market segment.
Aayush Wellness Other Announcement
The company filed a certificate from its Registrar and Share Transfer Agent confirming compliance with Regulation 74(5) for the quarter ended September 30, 2026.
Aayush Wellness Annual General Meeting
Aayush Wellness Limited conducted its 42nd Annual General Meeting on September 29, 2026, through video conferencing to transact standard annual business items.
Aayush Wellness Annual Report
Aayush Wellness Limited has submitted its Annual Report for the financial year 2025-26. The report includes financial statements, statutory reports, and corporate information.
Aayush Wellness Annual General Meeting
Aayush Wellness Limited has issued the notice for its 42nd Annual General Meeting scheduled for September 29, 2026. The meeting will be held via video conferencing.
Other other announcement announcements
All →Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.
Man Infraconstruction Other Announcement
Man Infraconstruction filed a Reg 32 quarterly statement confirming no deviation in use of preferential-warrant proceeds. No deviation or variation arose for the quarter ended September 30, 2026.
Black Buck Other Announcement
BlackBuck's ICRA monitoring agency report for Q1 FY27 confirms IPO proceeds utilization remains in line with stated objects. No deviation was observed in the quarter.
Raama Finance Other Announcement
Raama Finance appointed M/s. Kumar Gaurav & Co. as statutory auditor for three months effective October 29, 2026. The routine appointment carries no financial impact.
Teja Engineering Industries Other Announcement
Teja Engineering Industries filed a non-applicability certificate for Reg 27(2) Corporate Governance for Q1 FY27. As an NSE Emerge-listed SME, the company is exempt from this periodic disclosure.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.